BioLight Life Sciences Ltd. (TLV:BOLT)

BioLight Life Sciences Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5.73	9.72	5.28	13.39	33.47	29.99
Short-Term Investments	0.19	-	0.25	1.25	0.25	1.16
Trading Asset Securities	1.84	3.75	3.12	2.99	-	19.96
Cash & Short-Term Investments	7.76	13.47	8.64	17.63	33.71	51.11
Cash Growth	-42.17%	55.81%	-50.96%	-47.72%	-34.04%	27.93%
Other Receivables	0.87	-	-	-	0	0.09
Receivables	0.87	-	-	-	0	0.09
Prepaid Expenses	-	0.44	0.07	0.09	0.04	0.01
Other Current Assets	-	0.44	0.34	0.31	0.25	0.25
Total Current Assets	8.63	14.35	9.06	18.02	34	51.46
Property, Plant & Equipment	3.89	4.16	4.27	3.34	3.26	3.16
Long-Term Investments	12.33	13.53	19.37	34.88	25.82	10.06
Goodwill	-	-	-	-	-	0.15
Other Intangible Assets	0.69	0.69	0.69	0.69	0.15	-
Other Long-Term Assets	1.13	1.4	0.07	0.09	0.95	-
Total Assets	26.67	34.12	33.45	57.01	64.17	64.83
Accounts Payable	0.21	0.13	0.24	0.3	0.15	0.58
Accrued Expenses	-	1.4	1.51	1.71	1.62	1.52
Current Portion of Leases	0.34	0.53	0.09	0.53	0.44	0.46
Current Unearned Revenue	-	-	0.48	-	-	-
Other Current Liabilities	1.37	-	-	-	-	-
Total Current Liabilities	1.92	2.07	2.32	2.54	2.21	2.56
Long-Term Leases	-	0.07	-	-	-	0.47
Long-Term Unearned Revenue	1.15	1.25	0.84	0.78	0.54	0.56
Long-Term Deferred Tax Liabilities	-	-	-	-	-	1.13
Total Liabilities	3.08	3.38	3.15	3.32	2.75	4.72
Common Stock	276.65	11.65	11.65	11.44	11.4	11.36
Additional Paid-In Capital	-	251.1	250.78	250.46	250.42	248.34
Retained Earnings	-256.07	-249.97	-242.82	-216.8	-208.96	-209.34
Comprehensive Income & Other	-	14.1	10.17	8.07	7.84	8.86
Total Common Equity	20.58	26.88	29.78	53.17	60.7	59.22
Minority Interest	3.01	3.86	0.53	0.52	0.72	0.89
Shareholders' Equity	23.59	30.74	30.3	53.69	61.42	60.11
Total Liabilities & Equity	26.67	34.12	33.45	57.01	64.17	64.83
Total Debt	0.34	0.6	0.09	0.53	0.44	0.93
Net Cash (Debt)	7.42	12.87	8.55	17.1	33.27	50.18
Net Cash Growth	-41.00%	50.47%	-49.98%	-48.61%	-33.70%	27.04%
Net Cash Per Share	1.59	2.76	1.84	3.74	7.25	11.05
Filing Date Shares Outstanding	4.69	4.69	4.66	4.64	4.56	4.54
Total Common Shares Outstanding	4.69	4.66	4.66	4.58	4.56	4.54
Working Capital	6.71	12.28	6.74	15.49	31.79	48.9
Book Value Per Share	4.39	5.77	6.39	11.62	13.31	13.04
Tangible Book Value	19.89	26.19	29.09	52.48	60.55	59.07
Tangible Book Value Per Share	4.24	5.62	6.25	11.47	13.28	13.00
Machinery	-	0.56	0.64	0.64	0.54	0.54
Leasehold Improvements	-	-	0.07	0.07	0.07	0.19

Source: S&P Global Market Intelligence. Standard template. Financial Sources.